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ABSTRACT
Background Breathlessness is a multidimensional 
symptom prevalent in elderly affecting many aspects of 
life. We aimed to determine how different dimensions of 
breathlessness are associated with physical and mental 
quality of life (QoL) in elderly men.
Methods This was a cross- sectional, population- based 
analysis of 672 men aged 73 years in a Swedish county. 
Breathlessness was assessed using Dyspnoea- 12 (D- 12) 
and Multidimensional Dyspnoea Profile (MDP), and QoL 
using the Short Form 12 physical and mental scores. 
Scores were compared as z- scores across scales and 
analysed using multivariable linear regression, adjusted for 
smoking, body mass index and the presence of respiratory 
and cardiovascular disease.
Results Worse breathlessness was related to worse 
physical and mental QoL across all the D- 12 and MDP 
dimension scores. Physical QoL was most strongly 
associated with perceptional breathlessness scores, D- 12 
total and physical scores (95% CI −0.45 to −0.30). Mental 
QoL was more strongly influenced by affective responses, 
MDP emotional response score (95% CI −0.61 to −0.48). 
Head- to- head comparison of the instruments confirmed 
that D- 12 total and physical scores most influenced 
physical QoL, while mental QoL was mostly influenced by 
the emotional responses captured by the MDP.
Conclusion Breathlessness dimensions and QoL 
measures are associated differently. Physical QoL was 
most closely associated with sensory and perceptual 
breathlessness dimensions, while emotional responses 
were most strongly associated with mental QoL in elderly 
men. D- 12 and MDP contribute complimentary information, 
where affective and emotional responses may be related to 
function, deconditioning and QoL.
INTRODUCTION
Breathlessness is a dominant symptom in 
cardiorespiratory disease and other severe 
illnesses1 and is prevalent in the population, 
affecting the everyday life of about 20% of 
elderly (aged >70) in the community.2–5 
Chronic breathlessness6 often remains an 
invisible problem for healthcare profes-
sionals,7 even though it is an important cause 
of suffering, adverse events, health service 
utilisation and reduced function. It is strongly 
associated with poorer prognosis,8 anxiety, 
depression, fear9 and worse health- related 
quality of life (QoL).2
Breathlessness is a multidimensional 
symptom, influenced by different cognitive, 
physiological, psychological and environ-
mental factors.9 10 To gain an understanding 
of the person’s experienced symptom, 
multiple dimensions of breathlessness need 
to be considered including its intensity, 
sensory quality (descriptors), unpleasant-
ness/discomfort, emotional responses (such 
as anxiety, sense of depression or frustra-
tion) and its impact on QoL.2 Multidimen-
sional measurement is therefore important 
to adequately capture changes in the person’s 
health status and treatment effects. The 
high prevalence of depression and anxiety—
compounded by emotional responses to the 
symptom itself, may impair the person’s sense 
of self efficacy, function11 and further worsen 
QoL.12 13
Physical limitation from breathlessness, 
measured using the modified Medical 
Research Council (mMRC) score,14 has 
been associated with worse health- related 
QoL in adults, including both worse physical 
and mental QoL measured using the Short 
Form- 12 (SF- 12).2 15
Key messages
 ► Which breathlessness dimensions were associated 
with the physical and mental quality of life (QoL) in 
elderly men?
 ► Sensory and perceptual breathlessness dimensions 
were associated with physical QoL while emotional 
responses were associated with mental QoL.
 ► We show that different dimensions of breathlessness 
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Multiple dimensions of breathlessness can be assessed 
using the validated instruments Dyspnoea- 12 (D- 12)16 
and the Multidimensional Dyspnoea Profile (MDP).17 
Both instruments are widely used and MDP was recently 
validated in elderly people18 and used for patients with 
chronic obstructive pulmonary disease (COPD).19 
QoL can be assessed using a number of validated tools 
including the generic SF- 12.20 Neither the D- 12 nor 
the MDP used the SF- 12 (nor SF- 36) in their validation 
studies.
Data are limited on breathlessness in the general popu-
lation and in relation to QoL. Since this is a popula-
tional sample, we expected to find a lower prevalence of 
conditions and symptoms. In elderly patients’ symptoms 
are more common than at a younger age, and a study 
on a populational level can increase the knowledge of 
public health among elderly. Population studies have 
mainly used the mMRC scale, which relates to the activity 
or exertion required to induce breathlessness and not 
the severity of the breathlessness per se.14 No study has 
evaluated which dimensions of breathlessness that most 
strongly impact physical and mental QoL. This knowledge 
is important as different dimensions may have particu-
larly strong effects on different outcomes including QoL, 
and thus be important treatment targets.21 We hypothe-
sise that breathlessness dimensions associate differently 
with QoL, and that affective and emotional responses, 
such as anxiety and fear, most strongly influence mental 
QoL.
The primary aim of this study was to evaluate which 
dimensions of breathlessness, measured using D- 12 
and MDP, were most strongly associated with physical 
and mental QoL in elderly men in the general popu-
lation. Second, we performed a head- to- head compar-
ison between D- 12 and MDP, to evaluate which of their 
corresponding dimension scores (D12 total/MDP A1; 
D12 physical/MDP perception; D- 12 affective/MDP 
emotional) most independently and strongly captured 
physical and mental QoL.
METHODS
Study design and population
This was a cross- sectional, population- based analysis of 
73- year- old men in the VAScular disease and Chronic 
Obstructive Lung disease (VASCOL) study. The design 
and measurements of the VASCOL study has been detailed 
elsewhere.22 VASCOL included 1302 men aged 65 years 
in 2011–2012 who participated in screening for aortic 
aneurysm and who consented to participate in a longitu-
dinal follow- up study. No patient- reported outcomes were 
assessed at baseline. In 2019, a postal survey including 
validated Swedish versions D- 12,16 23 MDP17 24 and SF- 1220 
were sent to participants in the VASCOL study who were 
still alive and with a known address. The present analysis 
included participants who had available data on the eval-
uated D- 12, MDP and SF- 12 scores.
Assessments
Descriptives
Self- reported variables included height (cm), weight 
(kg), smoking status (current, former or never- smoker), 
smoking exposure (years and mean number of cigarettes 
per day) and the presence of physician diagnosed condi-
tions.22
Breathlessness
D- 12 comprises 12 items (descriptors) each scored a 
4- point scale of 0 (none), 1 (mild), 2 (moderate) or 3 
(severe).23 The first seven items pertain to the physical 
domain (D- 12 physical) of breathlessness, while the 
remaining five items pertain to the affective domain (D- 12 
affective). The range for D- 12 total score is 0–36: 0–21 
for the physical score; and 0–15 for the affective score. 
Higher D- 12 scores indicate worse breathlessness.23 D- 12 
is validated to be completed as a postal questionnaire.16
The MDP comprises 11 items which are rated on 0–10 
Numerical Rating Scales, divided into three domains 
that were evaluated: (1) the MDP A1 which is the total 
unpleasantness or discomfort of breathing; (2) the MDP 
perception score (range 0–60) which is the sum of A1 
and the intensities of five sensory qualities (muscle work 
or effort; air hunger; chest tightness or constriction; 
mental effort or concentration and breathing a lot); and 
(3) MDP emotional response score (range 0–50) with 
is the sum of the intensities for each of five emotional 
responses (depression; anxiety; frustration; anger and 
fright). Higher MDP scores reflect worse breathless-
ness.24 MDP is also validated to be completed as a postal 
questionnaire.17
Quality of life
SF- 12 comprises 12 items divided into a physical and a 
mental subscore with six questions and ranging 0–100 
each. Higher scores indicate worse QoL.20 22 Questions 
regarding the physical QoL include limitations in activ-
ities, accomplishments and pain interference, while the 
mental score pertains to questions on accomplishments, 
energy, mood and social time.
The time period used in this study for all breathlessness 
and QoL instruments was ‘during the last 2 weeks’.22 The 
V.2 of SF- 12 was used for the measurements.
Statistical analyses
Characteristics of the participants at the time of the ques-
tionnaire (baseline) were tabulated. Representativeness 
of the participants compared with the underlying popula-
tion sample was assessed by comparing characteristics at 
the initial assessment (2011–2012) between people who 
were included and not included in the present analysis. 
Sensitivity analysis for the included and excluded groups 
were analysed using χ2 test.
Associations for each breathlessness score for MDP (A1, 
perception and emotional response scores) and D- 12 
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and mental QoL scores were analysed using linear regres-
sion. MDP has a wider range (0–10) which makes it more 
suitable for linear regression compared with D- 12 (0–3) 
in which each score corresponds to a category. MDP was 
designed to be used mainly as individual scales, to measure 
one or several dimensions depending on the research 
question while D- 12 was constructed to yield a summary 
score to describe the overall level of breathlessness. 
Unadjusted and adjusted models were conducted for the 
potential confounders: body mass index (BMI), smoking 
status, pack- years of smoking, presence of cardiovascular 
disease (myocardial infarction, heart failure, valvopa-
thies, atrial fibrillation or stroke) and respiratory disease 
(COPD, asthma or other lung disease). Confounders 
were selected based on previous literature23 24 and subject 
matter knowledge using a directed acyclic graph (DAG; 
www. dagitty. net). Multicollinearity was checked with a 
correlation matrix of the included variables. Adjustment 
for age and sex was not needed; all participants were men 
aged 73 years. Level of physical activity was not included 
in the main model, as it could mediate (through decon-
ditioning) part of the effect of breathlessness on QoL. 
A sensitivity analysis also including physical activity was 
performed.
To compare the strength of associations between 
breathlessness dimensions and QoL, all breathlessness 
and QoL scores were log transformed to obtain a more 
normal distribution and converted into z- scores ([raw 
score − mean]/SD of the score). Z- scores are an estab-
lished method to enable comparisons of scores across 
scales with different ranges. Normality of the breathless-
ness scores and outcomes were assessed using distribution 
plots. Estimates were expressed with 95% CIs. Estimates 
are interpreted as the mean change (in SDs) of the QoL 
score for each SD increase in the breathlessness score.
For head- to- head comparison of the associations with 
QoL between D- 12 and MDP, regression models were 
conducted with the corresponding score from each 
instrument (D- 12 total/MDP A1; D12 physical/MDP 
perception; and D- 12 affective/MDP emotional, respec-
tively), adjusting for the confounders. The estimates are 
interpreted as the strength of association independent of 
that of the corresponding score of the other instrument. 
Statistical analyses were performed using Stata V.16.0.
Written individual informed consent was obtained 
from all participants.
Patient and public involvement
Patients or the public were not involved in the design, 




Out of the 1302 participants in the initial VASCOL popu-
lation sample in 2011–2012, 1193 (92%) participants 
were still alive and had a known address in 2019. Out of 
these participants, 907 (76%) participated in the 2019 
follow- up by returning the questionnaire. After exclusion 
of 235 participants due to missing data on D- 12, MDP or 
SF- 12, a total of 672 men aged 73 years were included in 
the analysis.
Participant characteristics are shown in table 1. Any 
breathlessness (score ≥1) was reported for mMRC by 97 
(14%), for D- 12 total by 196 (29%) and for MDP A1 by 
189 (28%). Moderate to severe breathlessness, defined 
as MDP A1 ≥4, was reported by 29 (4%). Compared with 
Table 1 Characteristics of 672 men aged 73 years from 
the general population
Factor Value
Age, mean (SD) 73.2 (0.7)
BMI, mean (SD) 27.2 (3.9)
Ever smoked, n (%) 436 (65.7)
Missing 8 (1.2)
  Pack- years of smoking, median (IQR) 5.4 (0–11.4)
Morbidities, n (%)
Respiratory disease 58 (8.6)
  Asthma 34 (5.1)
  COPD 26 (3.9)
  Other respiratory diseases 8 (1.2)
  Cardiovascular disease 201 (29.9)
  Angina pectoris 48 (7.1)
  Atrial fibrillation 104 (15.5)
  Heart failure 27 (4.0)
  Myocardial infarction 66 (9.8)
  Valvopathies 36 (5.4)
  Diabetes mellitus 93 (13.8)
  Rheumatological disease 31 (4.6)
  Stroke 50 (7.4)
Breathlessness and QoL
mMRC, n (%)
  0 447 (66.5)
  1 97 (14.4)
  2 54 (8.0)
  3 26 (3.9)
  4 32 (4.8)
  Missing 16 (2.4)
D- 12 total score, mean (SD) 1.66 (4.16)
D- 12 physical score, mean (SD) 1.08 (2.52)
D- 12 affective score, mean (SD) 0.57 (1.81)
MDP A1 unpleasantness score, mean (SD) 0.71 (1.37)
MDP perception score, mean (SD) 2.63 (6.48)
MDP emotional response score, mean (SD) 1.76 (5.09)
SF- 12 physical QoL, mean (SD) 46.66 (9.03)
SF- 12 mental QoL, mean (SD) 54.41 (8.93)
Data presented as mean (SD) or frequency (%). Percentages may not sum to 
100 due to overlapping categories.
BMI, body mass index; COPD, chronic obstructive pulmonary disease; D- 12, 
Dyspnoea- 12; MDP, Multidimensional Dyspnoea Profile; mMRC, modified 
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people excluded due to missing data, included partici-
pants had fewer current smokers (11% vs 15%; p=0.015) 
and fewer morbidities such as diabetes mellitus (7% vs 
13%; p<0.001), online supplemental table S1.
Breathlessness dimensions and QoL
Associations of different breathlessness dimensions with 
QoL are shown unadjusted (online supplemental table 
S2) and adjusted for confounders in table 2. Worse 
breathlessness was independently associated with worse 
physical and mental QoL, across all the D- 12 and MDP 
scores. However, the strength of associations differed 
between the breathlessness dimensions. Physical QoL was 
most strongly associated with the D- 12 scores and MDP 
A1. In contrast, mental QoL was most strongly associated 
with the MDP emotional response summary score (−0.50; 
95% CI −0.57 to −0.43) and across the individual MDP 
emotional responses (table 2).
Comparison of D-12 and MDP
To explore which of the instruments’ dimension scores 
that were most strongly and independently associated 
with the QoL outcomes, the corresponding scores from 
D- 12 and MDP were evaluated concurrently in the same 
models ‘head- to- head’, as shown in table 3.
This analysis confirmed that physical QoL was most 
strongly associated with the D- 12 scores. When adjusting 
for the corresponding D- 12 score, the MDP A1 and 
subdomain scores no longer showed any independent 
association with physical QoL.
Mental QoL was most strongly associated with the MDP 
emotional response score, which was the strongest among 
all evaluated associations (−0.51; 95% CI, −0.61 to −0.42), 
table 3. Controlling for MDP emotional response, the D- 12 
affective score showed no independent association with 
mental QoL. The findings were similar in a sensitivity analysis 
also adjusting for the level of physical activity.
DISCUSSION
Main findings
Worse breathlessness, across all dimensions measured 
using D- 12 and MDP, was strongly associated with worse 
physical and mental QoL. These associations were inde-
pendent of potential confounders including smoking, 
BMI and the presence of respiratory and cardiovascular 
Table 2 Association for each breathlessness dimension with physical or mental quality of life assessed using the Short Form 
12 (SF- 12)
Association with SF- 12 physical 
score, adjusted* beta (95% CI)
Association with SF- 12 mental 
score, adjusted* beta (95% CI)
D- 12
  Total score −0.38 (−0.46 to −0.31) −0.37(−0.45 to −0.29)
  Physical score −0.38 (−0.45 to −0.30) −0.36 (−0.44 to −0.28)
  Affective score −0.33 (−0.4 to −0.26) −0.33 (−0.41 to −0.25)
MDP
  A1 unpleasantness score −0.33 (−0.40 to −0.25) −0.34 (−0.42 to −0.26)
  Perception score −0.30 (−0.37 to −0.22) −0.32 (−0.40 to −0.24)
  Emotional response score −0.24 (−0.31 to −0.17) −0.50 (−0.57 to −0.43)
  Descriptors
  Muscle work or effort −0.23 (−0.30 to −0.15) −0.25 (−0.33 to −0.17)
  Air hunger −0.23 (−0.30 to −0.16) −0.25 (−0.33 to −0.16)
  Chest tightness or constriction −0.21 (−0.28 to −0.14) −0.27 (−0.35 to −0.19)
  Mental effort or concentration −0.21 (−0.28 to −0.14) −0.27 (−0.35 to −0.19)
  Breathing a lot −0.17 (−0.24 to −0.10) −0.21 (−0.29 to −0.13)
  Emotional responses
  Depression −0.17 (−0.24 to −0.09) −0.55 (−0.61 to −0.48)
  Anxiety −0.21 (−0.28 to −0.14) −0.51 (−0.59 to −0.44)
  Frustration −0.24 (−0.31 to −0.17) −0.44(−0.51 to −0.36)
  Anger −0.18 (−0.25 to −0.10) −0.41 (−0.49 to −0.34)
  Fright −0.21 (−0.28 to −0.14) −0.46 (−0.54 to −0.39)
To be able to compare the strengths of the associations between the different scales, all scores were log transformed (to 
yield more normal distributions) and analysed as z- scores. Associations are by linear regression each breathlessness score 
separately, adjusted for confounders.
*Adjusted for the confounders smoking history, packet- years, BMI, respiratory diseases, and cardiovascular diseases.
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disease. However, breathlessness dimensions influ-
enced QoL differently. Physical QoL was most strongly 
related to sensory and perceptual dimension scores 
most strongly captured by D- 12. In contrast, mental 
QoL associated most strongly with emotional responses 
to breathlessness captured by the MDP.
What this study adds
This is the first study to incorporate D- 12 and MDP into 
the health assessment of the participants in a general 
population sample. We expected to find a lower prev-
alence of breathlessness in our populational sample. 
The findings extend those of the cross- sectional study 
by Currow et al that worsening disability from chronic 
breathlessness (measured using mMRC) was associated 
with increasingly impaired physical and mental QoL in 
an adult population, majority of the adults were non- 
smokers aged between 15–44 years.2
Morélot- Panzini et al also showed high correlates 
of MDP- A2 with SF- 12 mental component and HADS 
in patients with COPD.25 We now show that different 
dimensions of breathlessness are associated with worse 
physical and mental QoL, and that the strengths of the 
associations differ between breathlessness dimensions 
and by type of QoL. D- 12 scores were more strongly asso-
ciated with the physical QoL, while emotional responses 
to breathlessness measured using the MDP most 
strongly influenced mental QoL. This is the first head- 
to- head comparison of D- 12 and MDP, showing that the 
instruments contribute complementary information. 
D- 12 captured both physical and mental factors—in 
line with the aim, development and multidimensional 
nature of the instrument26—while MDP most strongly 
captured affective and emotional responses strongly 
linked to mental QoL. This analysis also showed that 
when analysing physical QoL with D- 12 and mental 
QoL using MDP, respectively, measuring and adding 
the corresponding score from the other instrument 
added no further independent information in terms of 
their association with QoL.
The present findings are in line with report that 
breathlessness catastrophising (exaggerated negative 
cognitive- emotional orientation towards an actual or 
anticipated noxious stimuli) was related to poorer QoL 
in adults with cystic fibrosis,27 and that depression, pain 
and a less constructive emotional response to breath-
lessness are unique predictors of poorer health- related 
QoL. This might have therapeutic implications as, 
like in pain catastrophising, a more adverse affective 
and emotional response to breathlessness (such as in 
breathlessness catastrophising) may undermine the 
response to the interventions28 including to opioids.29 
High scores of emotional responses might be related to 
less effective mental coping which could be measured 
with Coping Scale for Adults.
Strengths and limitations
Strengths of this study include the use of validated and 
established multidimensional breathlessness instru-
ments, the relatively large sample size and available data 
that allowed several potentially important confounders 
to be addressed in the analysis. Another strength is 
that SF- 12 V.2 is a valid instrument with independent 
subscales, which are not correlated with one another as 
shown by Ware et al.30
A limitation of this study is the fact that only 
73- year- old men were studied, they were only included 
because only men participated in the VASCOL study. 
While this effectively avoids any bias related to sex 
and age, generalisability for women and other age 
groups may be limited, and future follow- ups in the 
VASCOL study is planned to also include women and 
younger age groups.22 Also, most participants were 
relatively healthy and few reported severe breathless-
ness, which is to be expected in a population sample 
like this. The prevalence of COPD and asthma is 
slightly lower but like other studies of men and women 
in the same age, and as expected the prevalence of 
COPD is higher in our study than studies of younger 
age groups.31 32 Suggested next steps are to evaluate 
the impact of different breathlessness dimensions in 
people with more severe underlying disease and severe 
breathlessness.
Table 3 Comparison between D- 12 and MDP of 
associations with physical and mental quality of life, 
adjusted for confounders





−0.32 (−0.42 to −0.21)
A1
−0.09 (−0.20 to 0.02)
Physical
−0.33 (−0.44 to −0.22)
Perception
−0.06 (−0.16 to 0.04)
Affective
−0.30 (−0.39 to −0.21)
Emotional response





−0.27 (−0.39 to −0.14)
A1
−0.14 (−0.26 to −0.01)
Physical
−0.26 (−0.38 to −0.14)
Perception
−0.13 (−0.25 to −0.01)
Affective
0.01 (−0.08 to 0.11)
Emotional response
−0.51 (−0.61 to −0.42)
Associations of corresponding scores of D- 12 and the 
MDP, analysed concurrently in the same model, with 
physical and mental QoL. QoL was assessed using the 
SF- 12 questionnaire. To be able to compare the strengths 
of the associations between the different scales, all scores 
were log transformed (to yield more normal distributions) 
and analysed as z- scores.
All models were adjusted for the confounders smoking 
history, packet- years, BMI, cardiovascular diseases, and 
respiratory diseases.
BMI, body mass index; D- 12, Dyspnoea- 12; MDP, 
Multidimensional Dyspnoea Profile; QoL, quality of life; SF- 
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Implications
The present findings have several implications. First, 
the differing associations with QoL support the impor-
tance of measuring multiple dimensions of breathless-
ness and that D- 12 and MDP contribute complemen-
tary information. Moreover, the instruments may be 
more useful for capturing certain aspects of breath-
lessness and QoL, as shown for D- 12 in terms of phys-
ical QoL, and MDP emotional responses which most 
strongly captured influence on mental QoL. In relation 
to these associations with QoL, adding measuring with 
the other instrument (D- 12 or MDP) did not contribute 
any independent information—but this is likely to vary 
depending on the aim of the measurement and the 
outcome.
The present findings can be interpreted to support 
the hypothesis that certain dimensions—especially 
stronger affective and emotional reactions, are more 
likely to induce behavioural adaptation, leading to 
the vicious circle of inactivity, deconditioning and 
worsening symptoms.33 34 For research, our find-
ings can be relevant when selecting the appropriate 
instruments and scales in studies of breathlessness 
and QoL. The reliability and usefulness of the instru-
ments for symptom monitoring in clinical practice 
is unknown. Further studies are also needed on the 
impact of different breathlessness dimensions on other 
outcomes, such as self- efficacy and mental coping with 
chronic breathlessness, function and on the effect of 
symptomatic treatments.
Conclusion
Across all dimensions, worse breathlessness is associ-
ated with worse physical and mental QoL. Physical QoL 
was most strongly correlated with sensory and percep-
tual dimensions scores, most strongly captured by D- 12, 
whereas MDP emotional responses of breathlessness 
most strongly influenced mental QoL in elderly men in 
the population.
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